Divi's Laboratories Ltd. (DIVI)

Currency in INR
6,168.50
-16.50(-0.27%)
Closed·
DIVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6,054.006,200.00
52 wk Range
4,955.007,071.50
Key Statistics
Bid/Ask
6,165.00 / 6,168.50
Prev. Close
6,168.5
Open
6,141
Day's Range
6,054-6,200
52 wk Range
4,955-7,071.5
Volume
299.36K
Average Volume (3m)
337.86K
1-Year Change
5.5572%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DIVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6,870.09
Upside
+11.37%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Divi's Laboratories Ltd. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Divi's Laboratories Ltd. Company Profile

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as lutein and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

Employees
10542
Market
India

Compare DIVI to Peers and Sector

Metrics to compare
DIVI
Peers
Sector
Relationship
P/E Ratio
66.1x40.3x−0.5x
PEG Ratio
3.310.350.00
Price/Book
10.6x3.4x2.6x
Price / LTM Sales
15.9x3.8x3.3x
Upside (Analyst Target)
11.5%15.7%47.1%
Fair Value Upside
Unlock4.1%5.8%Unlock

Analyst Ratings

15 Buy
5 Hold
11 Sell
Ratings:
31 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6,870.09
(+11.37% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Axis Capital Limited
Sell6,660.00+7.97%6,720.00MaintainFeb 12, 2026
Kotak
Sell5,500.00-10.84%6,000.00MaintainFeb 12, 2026
JPMorgan
Buy7,300.00+18.34%7,800.00MaintainFeb 12, 2026
Jefferies
Buy8,000.00+29.69%7,850.00MaintainJan 09, 2026
Citi
Buy9,140.00+48.17%-MaintainJan 06, 2026

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 93.37%
Dividend Yield
0.49%
Industry Median 0.78%
Annualized payout
30.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 10, 2026
EPS / Forecast
21.98 / 23.46
Revenue / Forecast
26.04B / 26.52B
EPS Revisions
Last 90 days

DIVI Income Statement

People Also Watch

141.77
CNBK
-2.10%
626.40
DLF
-3.90%
285.20
ETEA
-4.30%
592.85
HZNC
-4.95%
3,864.60
TVSM
-0.43%

FAQ

What Is the Divi's Labs (DIVI) Stock Price Today?

The Divi's Labs stock price today is 6,168.50

What Stock Exchange Does Divi's Labs Trade On?

Divi's Labs is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Divi's Labs?

The stock symbol for Divi's Labs is "DIVI."

Does Divi's Labs Pay Dividends? What’s The Current Dividend Yield?

The Divi's Labs dividend yield is 0.49%.

What Is the Divi's Labs Market Cap?

As of today, Divi's Labs market cap is 1.64T.

What Is Divi's Labs's Earnings Per Share (TTM)?

The Divi's Labs EPS (TTM) is 93.37.

When Is the Next Divi's Labs Earnings Date?

Divi's Labs will release its next earnings report on May 25, 2026.

From a Technical Analysis Perspective, Is DIVI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Divi's Labs Stock Split?

Divi's Labs has split 3 times.

How Many Employees Does Divi's Labs Have?

Divi's Labs has 10542 employees.

What is the current trading status of Divi's Labs (DIVI)?

As of Feb 16, 2026, Divi's Labs (DIVI) is trading at a price of 6,168.50, with a previous close of 6,168.50. The stock has fluctuated within a day range of 6,054.00 to 6,200.00, while its 52-week range spans from 4,955.00 to 7,071.50.

What Is Divi's Labs (DIVI) Price Target According to Analysts?

The average 12-month price target for Divi's Labs is INR6,870.09, with a high estimate of INR9140 and a low estimate of INR5140. 15 analysts recommend buying the stock, while 11 suggest selling, leading to an overall rating of Neutral. The stock has an +11.37% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.